All In Biotech

Free tool

FAERS Monitor: Suprane

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020118 or its brand name (Suprane, Desflurane). Reports on generic versions are filed under their own applications.

Reports

1,717

Serious

1,636

95% of reports

Hospitalization

664

Death reported

112

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hypotension119
  • bradycardia103
  • cardiac arrest99
  • drug interaction97
  • anaphylactic shock93
  • serotonin syndrome74
  • hyperthermia malignant64
  • anaphylactic reaction59
  • bronchospasm58
  • drug ineffective58
  • tachycardia57
  • foetal exposure during pregnancy48
  • post procedural complication42
  • blood pressure decreased41
  • circulatory collapse37

Reports by year received

View as table
YearReports
200420
200537
200636
200730
200857
200955
201068
201166
201295
2013118
2014105
2015120
2016108
2017116
2018138
2019114
202084
202176
202261
202365
202464
202546
202637

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,442 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperthermia malignantSignal64550.7430.633,084
bronchospasmSignal5850.038.82,726
serotonin syndromeSignal7447.437.93,303
anaphylactic shockSignal9344.436.43,889
post procedural complicationSignal4226.819.91,018
circulatory collapseSignal3726.719.4887
bradycardiaSignal10323.819.82,232
cardiac arrestSignal9914.712.11,254
anaphylactic reactionSignal5913.110.2648
tachycardiaSignal577.96.1336
blood pressure decreasedSignal417.65.6228
drug interactionSignal977.56.2543
hypotensionSignal1197.36.1643
foetal exposure during pregnancySignal487.25.5253
drug ineffective580.50.424

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.